Dusk And Dawn In Emerging Markets? Pharmas Find Growth Elsewhere Offset Turkish Price Cuts

Each market is different, but even more so in emerging markets. The world's sixth-largest drug maker Novartis' first quarter results showed that strong growth from top pharmemerging markets, China, India, Brazil, and South Korea "more than" offset an across-the-board drug price cut in Turkey